New Delhi: People taking GLP-1 receptor agonist drugsmedications that help control blood sugar and reduce appetiteespecially semaglutide, face a modestly increased risk of developing a rare and potentially blinding eye disorder compared to those on a different class of diabetes medication, a large study has found
Some patients with asymptomatic (silent) small hiatal hernias may have no issues with semaglutide, while those with large hernias causing daily symptoms may need additional precautions, such as proton pump inhibitor therapy or dose adjustments
Molecular biology of 5,10-methylenetetrahydrofolate reductase
Kontinuiranost Da bismo ostvarili najbolje standarde, nae odgojiteljice kontinuirano prate i primjenjuju najnovije spoznaje s podruja predkolskog odgoja i obrazovanja kod nas i u svijetu.
Empagliflozin and cardiovascular outcomes in patients with type 2 diabetes and left ventricular hypertrophy: a subanalysis of the EMPA-REG OUTCOME trial
(PubMed) L-carnitine: reviews and systematic analysis show improvement in motility and morphology